NCT05014841
Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER+, PR+
Other Mutations:
Breast Cancer Tissue:
Recruitment Status: Recruiting
Not Applicable
Drug Category: Other
Key Eligibility Criteria:
Gender: All
Age: 18 Years to 70 Years (Adult, Older Adult)
Location of Metastases: Brain
Additional Notes: Patients must be scheduled to undergo surgical electrode implantation for seizure localization or for speech and language mapping
Exclusions:
https://ClinicalTrials.gov/show/NCT05014841